Juan Luis Onieva

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Instituto de Investigación Biomédica de Málaga(Current)

Universidad de Málaga

Karolinska Institutet

Andalusian Centre for Nanomedicine and Biotechnology

Hospital Universitario de Gran Canaria Doctor Negrín

Juan Luis Onieva is an author at Instituto de Investigación Biomédica de Málaga specializing in checkpoint inhibitor therapy, oncology, and molecular oncology.

ORCID

Publications per year

2022–2024

Publications

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Rodolfo Chicas-Sett, Juan Zafra, Delvys Rodríguez‐Abreu et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 44 citations

Medicine, Oncology, Pharmacotherapy +14

High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade

Juan Luis Onieva, Qingyang Xiao, Miguel‐Ángel Berciano‐Guerrero et al. · International Journal of Molecular Sciences · 2022 · 30 citations · Full text

Medicine, Immunology, Oncology +17

Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer

Juan Zafra, Juan Luis Onieva, Javier Oliver et al. · International Journal of Molecular Sciences · 2024 · 14 citations · Full text

Medicine, Immunology, Oncology +17

Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma

Javier Oliver, Juan Luis Onieva, María Garrido-Barros et al. · Biomedicines · 2022 · 10 citations · Full text

Medicine, Immunology, Oncology +17

1–4 of 4